I'm looking
for help...
Aidpage is free!

Free downloads: GrantGate®  Federal Money Retriever®


Published on AidPage by IDILOGIC on Jun 24, 2005
Administered by:

Department of Health and Human Services, National Institutes of Health, National Institutes of Health
(see all US Federal Agencies)

Explore all postings for this grant program:
  • Original Grant - Sep 8, 2004
Applications Due:

Multiple Receipt Dates - See Link to Full Announcement for details.

total funding: Not Available
max award: $250,000
min award: none
cost sharing, matching: No
number of awards: Not Available
type of funding: Grant

Continuing progress in basic cancer research and drug development has led to
discoveries of new agents or approaches for molecular targeting in novel
cancer therapies. These new agents or approaches suppress tumor growth
through multiple mechanisms such as cell cycle control, activation of tumor
suppressor genes, essential signal pathway blockage, tumor vaccines, tumor
microenvironment modification, etc. Rapid translation of these exciting
discoveries into clinical practice requires timely support to accommodate the
special needs of novel cancer therapy development. This Program Announcement
(PA) is intended to provide investigators with rapid access to support for
pilot, Phase I, and Phase II cancer clinical trials as well as support for
patient monitoring and laboratory studies linked to a cancer clinical trial.
Phase III trials are not excluded but such trials generally require greater
resources and duration than available from an R21 award. Applications that
do not propose a cancer clinical trial or patient monitoring or laboratory
studies linked to a cancer clinical trial may be returned to applicants
without being reviewed. The focus of this QUICK-TRIAL PA is on translational
research in new agent development to ensure the timely exploitation of new
cancer therapeutic approaches including the development of new cancer
prevention agents. This PA is aimed at providing a new approach in the grant
application process by offering a rapid turnaround from application
submission to funding. Features of this initiative include a modular grant
application and award process, inclusion of the clinical protocol within the
grant application, and an accelerated peer review with the goal of issuing
new awards within six months of application receipt. Inclusion of the
complete clinical protocol within the PHS 398 grant application is intended
to simplify the application process by eliminating the need to duplicate
protocol details in the Research Plan section and to insure proper peer
review of the application. In addition, QUICK-TRIAL applications do not
require extensive preliminary data in the grant application and support
exploratory translational and clinical research studies involving cancer
prevention, chemotherapy and rapid development and application of novel
clinical cancer therapies including image guided therapeutic procedures.
Investigators may apply for a maximum of two years of funding support using
the exploratory or developmental (R21) grant mechanism for up to $250,000
direct costs per year.

Who can apply:

Anyone/General Public
City Or Township Governments
County Governments
Federally Recognized Indian Tribal Governments
Independent School Districts
Minority Group
Native American Organization
Non-Government - General
Nonprofits Having A 501(C)(3) Status With The IRS, Other Than Institutions Of Higher Education
Nonprofits That Do Not Have A 501(C)(3) Status With The IRS, Other Than Institutions Of Higher Education
Other Private Institution/Organization
Private Institutions Of Higher Education
Private Nonprofit Institution/Organization (Includes Institutions Of Higher Education, Hospitals)
Profit Organization
Public And State Controlled Institutions Of Higher Education
Public Housing Authorities/Indian Housing Authorities
Quasi-Public Nonprofit Institution/Organization
Small Business (Less Than 500 Employees
Special District Governments
State (Includes District Of Columbia; Includes Institutions Of Higher Education And Hospitals)
U.S. Territories And Possessions (Includes Institutions Of Higher Education, Hospitals)

Eligible functional categories:
Funding Sources:

Cancer Cause and Prevention Research
Cancer Detection and Diagnosis Research
Cancer Treatment Research

More Information:


If you have problems accessing the full announcement, please contact: NIH OER Webmaster

Address Info:

Free downloads: GrantGate®  Federal Money Retriever®
Apply for grants and loans! Click here to start